{"id":5047,"date":"2013-06-17T09:00:00","date_gmt":"2013-06-17T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/"},"modified":"2024-09-23T11:22:43","modified_gmt":"2024-09-23T11:22:43","slug":"financiering-voor-onderzoek-daniel-pipeleers","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/","title":{"rendered":"Financiering voor onderzoek Daniel Pipeleers"},"content":{"rendered":"<strong>Op de Breakthrough T1D Walk 2013 kon Breakthrough T1D bekend maken dat prof. dr. Daniel Pipeleers van de Vrije Universiteit Brussel samen met prof. dr. Bart Roep van het Leids Universitair Medisch Centrum en hun onderzoeksteams een Breakthrough T1D-beurs van 1.980.000 dollar krijgen voor onderzoek naar de ontwikkeling van ingekapselde b\u00e8tacellen die veilig en normaal insuline leveren aan mensen met Type 1 Diabetes (T1D).<\/strong>\n\nPipeleers en Roep werken samen binnen het <a href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/inkapseling\/\" target=\"_blank\" rel=\"noreferrer noopener\">Breakthrough T1D Inkpaselingsconsortium<\/a>. Dr. Paul de Vos van de Rijksuniversiteit Groningen en dr. Aart van Apeldoorn van de Universiteit Twente zijn tevens binnen dit consortium actief.\n\n<a href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/2-miljoen-voor-onderzoek-celtherapie\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lees meer over het onderzoek en zie de reacties van Maarten de Groot en prof. dr. Daniel Pipeleers.<\/a>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Op de Breakthrough T1D Walk 2013 kon Breakthrough T1D bekend maken dat prof. dr. Daniel Pipeleers van de Vrije Universiteit Brussel samen met prof. dr. Bart Roep van het Leids Universitair Medisch Centrum en hun onderzoeksteams een Breakthrough T1D-beurs van 1.980.000 dollar krijgen voor onderzoek naar de ontwikkeling van ingekapselde b\u00e8tacellen die veilig en normaal [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,196],"tags":[],"class_list":["post-5047","post","type-post","status-publish","format-standard","hentry","category-archief","category-betacelvervanging"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Financiering voor onderzoek Daniel Pipeleers - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Financiering voor onderzoek Daniel Pipeleers - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Op de Breakthrough T1D Walk 2013 kon Breakthrough T1D bekend maken dat prof. dr. Daniel Pipeleers van de Vrije Universiteit Brussel samen met prof. dr. Bart Roep van het Leids Universitair Medisch Centrum en hun onderzoeksteams een Breakthrough T1D-beurs van 1.980.000 dollar krijgen voor onderzoek naar de ontwikkeling van ingekapselde b\u00e8tacellen die veilig en normaal [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-17T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:43+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Financiering voor onderzoek Daniel Pipeleers\",\"datePublished\":\"2013-06-17T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\"},\"wordCount\":123,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"articleSection\":[\"Archief\",\"B\u00e8tacelvervanging\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\",\"name\":\"Financiering voor onderzoek Daniel Pipeleers - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"datePublished\":\"2013-06-17T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Financiering voor onderzoek Daniel Pipeleers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Financiering voor onderzoek Daniel Pipeleers - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/","og_locale":"nl_NL","og_type":"article","og_title":"Financiering voor onderzoek Daniel Pipeleers - Breakthrough T1D","og_description":"Op de Breakthrough T1D Walk 2013 kon Breakthrough T1D bekend maken dat prof. dr. Daniel Pipeleers van de Vrije Universiteit Brussel samen met prof. dr. Bart Roep van het Leids Universitair Medisch Centrum en hun onderzoeksteams een Breakthrough T1D-beurs van 1.980.000 dollar krijgen voor onderzoek naar de ontwikkeling van ingekapselde b\u00e8tacellen die veilig en normaal [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/","og_site_name":"Breakthrough T1D","article_published_time":"2013-06-17T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:43+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Financiering voor onderzoek Daniel Pipeleers","datePublished":"2013-06-17T09:00:00+00:00","dateModified":"2024-09-23T11:22:43+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/"},"wordCount":123,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief","B\u00e8tacelvervanging"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/","name":"Financiering voor onderzoek Daniel Pipeleers - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2013-06-17T09:00:00+00:00","dateModified":"2024-09-23T11:22:43+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Financiering voor onderzoek Daniel Pipeleers"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5047"}],"version-history":[{"count":2,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5047\/revisions"}],"predecessor-version":[{"id":8945,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5047\/revisions\/8945"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}